Search for: "SANDOZ INTERNATIONAL GmbH"
Results 21 - 40
of 47
Sort by Relevance
|
Sort by Date
23 Feb 2015, 2:55 am
.* The Richemont ruling and beyond: dealing with counterfeit websites and the intermediaries that host themKatfriend Tim Behean provides another insightful analysis of Cartier International AG and Others v British Sky Broadcasting Ltd and Others [2014] EWHC 3354 (Ch) [following Eleonora's Katpost here], explaining what Arnold J's decision has achieved, how they go about dealing with blocking injunctions in the United States -- and where we might go from here.*… [read post]
16 Feb 2015, 1:44 am
* "Fool's errand": no need to create your own brand if you can use someone else's Jeremy notes Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH [2015] EWCA Civ 54 [on which see earlier katpost here], a trade mark infringement decision of the Court of Appeal, England and Wales, on parallel importation and over-stickering of pharmaceutical products. [read post]
3 Feb 2015, 10:53 am
Sandoz at 5-6 (internal citations omitted). [read post]
13 Mar 2013, 4:45 am
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
6 Feb 2013, 12:00 am
Bodenseewerk Perkin-Elmer GmbH, 386 F.3d 1133, 1138 (Fed. [read post]
15 Jan 2013, 11:33 am
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
19 Oct 2012, 6:13 pm
Assets related to four of the markets would be divested to Sandoz International GmbH, a subsidiary of Novartis AG. [read post]
9 May 2012, 12:49 pm
Sandoz International GmbH, et. al., 3-09-cv-04591 (NJD May 4, 2012, Order) (Cooper, J.) [read post]
28 Mar 2012, 8:30 am
According to court filings, the shipments of thiopental entering the United States came from an Austrian facility owned by Sandoz International GmbH. [read post]
25 Feb 2011, 8:02 am
The packaging indicated the drug was made by Sandoz International GmbH, a European generics company, Kentucky Justice and Public Safety Cabinet spokeswoman Jennifer Brislin said. [read post]
23 Feb 2011, 9:51 am
And: The packaging indicated the drug was made by Sandoz International GmbH, a European generics company, Brislin said, with an expiration date of May 2014.Marija Mandic, a spokeswoman for Sandoz, based in Hozkirchen, Germany, said the company does not market sodium thiopental in the U.S. [read post]
3 Feb 2011, 8:39 am
The shipments of thiopental entering the U.S. originated from an Austrian facility owned by Sandoz International GmbH, a German company, according to the complaint. [read post]
16 Sep 2010, 9:54 pm
Foreign defendants Sandoz International GmbH and Novartis were... [read post]
27 May 2010, 3:20 am
Boehringer Ingelheim International GMBH et al. [read post]
13 May 2010, 4:58 pm
(FDA Law Blog) US: Divisional of a divisional: Avoid terminal disclaimers: CAFC denies en banc rehearing in Boehringer Ingelheim International GMBH v. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
17 Feb 2010, 8:00 am
Sandoz Inc. [read post]
25 Nov 2009, 3:00 am
Pro-Football, Inc (The IP Factor) (TTABlog) Brazil gets closer to listing US IP retaliation targets (IP tango) Global Global - General Why the lack of ACTA transparency is not standard (Michael Geist) WIPO, a (rare) profitable UN agency, ventures into world of donors (IP Watch) WIPO Director wraps up official visit to India topped by meeting with Prime Minister (WIPO) Delegates look to April for consensus on development agenda coordination (IP Watch) International conference calls… [read post]
28 Aug 2009, 8:11 am
Sandoz International GmbH and Sandoz Inc. [read post]
9 Aug 2009, 4:54 pm
KG; Boehringer Ingelheim International GmbH Declaratory judgment of invalidity, unenforceability, and non-infringement of U.S. [read post]
